第四季度，菲利普的可比订单量增长了2%，其中北美和增长市场表现强劲，但部分被中国市场需求的两位数下降所抵消。集团的可比销售额在本季度增长了1%，而除中国外的其他地区实现了5%的稳健增长，但被中国市场两位数的下降基本抵消。市场状况预期在中国仍然不确定。调整后EBITA在第四季度提升了60个基点，达到13.5%，这得益于运营改进和生产力措施。自由现金流在该季度增长至13亿欧元，这主要得益于Respironics保险收益，部分被营运资本的阶段性变化所抵消。

以上内容来自Benzinga Earnings专栏，原文如下：

Comparable order intake increased 2% in the quarter, with strong performance in the North America and Growth geographies, partly offset by a double-digit decline in demand in China. Group comparable sales increased 1% in the quarter, with solid growth of 5% in the rest of the world, largely offset by a double-digit decline in China, where market conditions are expected to remain uncertain. 

Adjusted EBITA increased 60 basis points to 13.5% in Q4, driven by operational improvements and productivity measures. Free cash flow increased to EUR 1.3 billion in the quarter, driven by Respironics insurance proceeds, partly offset by phasing in working capital